Study of microRNA in Pulmonary Tuberculosis
Not Applicable
- Conditions
- Health Condition 1: A150- Tuberculosis of lung
- Registration Number
- CTRI/2023/08/056740
- Lead Sponsor
- Dr Swathy Moorthy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
cohort 1A : sputum positive Pulmonary Tuberculosis patients who will be classified as cavitatory type on chest X ray or CT scan
cohort 1B : sputum positive Pulmonary Tuberculosis patients who will be classified as non cavitatory type - no cavity on chest X ray or CT scan
Exclusion Criteria
age more than 60 and less than 18 years, current smoking or alcoholism, presence of any prior chronic medical illness, pregnancy, drug resistant tuberculosis, tuberculosis patients with HIV co-infection, previously treated with ATT or other active lung infection like community acquired pneumonia, on steroids, anti inflammatory, anti convulsants, anti cancer drugs
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method get the microRNA profile of sputum positive Pulmonary Tuberculosis patientsTimepoint: at the end of two years once all sample are collected analysis will be done
- Secondary Outcome Measures
Name Time Method identify the upregulated & downregulated microRNA in the sputum positive Pulmonary TuberculosisTimepoint: 3 years